Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
COVID-19
RSV (Respiratory syncytial virus)
NITAG documentation
Adults
Children
Americas
Clear all
Type of publications
NITAG documentation
(6)
Systematic reviews (SYSVAC)
(4)
Topics
Background paper
(2)
Recommendation
(4)
Available to download in languages
English (EN)
(5)
Spanish (ES)
(1)
Regions
Americas
(6)
Africa
(1)
Europe
(4)
Western Pacific
(3)
Countries
Bolivia
(1)
Canada
(2)
United States of America
(3)
Diseases
COVID-19
(5)
RSV (Respiratory syncytial virus)
(1)
Hepatitis A
(1)
Hepatitis B
(1)
Herpes zoster
(1)
Human papillomavirus (HPV)
(2)
Influenza
(3)
Japanese encephalitis
(2)
Meningococcal disease
(1)
Mumps
(1)
Pertussis
(1)
Pneumococcal disease
(5)
Rabies
(1)
Vaccine topics
Target population
Adults
(1)
Children
(5)
Adolescents
(1)
Healthcare workers
(2)
Newborn
(1)
Older adults
(4)
Pregnant women
(5)
Risk group
(3)
Publication date
2023
(1)
2022
(1)
2021
(4)
6 results found
2023
∙
ACIP
Use of Nirsevimab for the Prevention of Respiratory Syncytial Virus Disease Among Infants and Young Children: Recommendations of the Advisory Committee on Immunization Practices
2022
∙
NACI
Updated recommendations on the use of COVID-19 vaccine booster doses in children 5 to 11 years of age and concurrent vaccine administration
2021
∙
Comité Nacional de Inmunización (CNI)
Vaccination, prevention against COVID in children under 12 years old in Bolivia
2021
∙
ACIP
COVID-19 Vaccines for Children
2021
∙
ACIP
Epidemiology of COVID-19 in Children and Teens
2021
∙
NACI
NACI rapid response: Recommended use of AstraZeneca COVID-19 vaccine in younger adults
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register